Invasive Prostate Carcinoma — Trials

Invasive Prostate Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

440 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 139
Recruiting: 65
Ph III recruiting: 5
Growth YoY: —
Industry share: 4%
Top sponsor: Jonsson Comprehensive Cancer Center
Termination share: 31.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (72)

clinicaltrialsPublishedShowing 51–72 of 72 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03902951	Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate Cancer	active not recruiting	Phase 2	28	Jonsson Comprehensive Cancer CenterOTHER	1	Feb 5, 2026	clinicaltrials
NCT04455750	A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testosterone-Deprivation Therapy(CASPAR)	active not recruiting	Phase 3	61	Alliance for Clinical Trials in OncologyOTHER